The present invention is directed to a fluorescent polarization assay for acetaminophen, to the various components needed for preparing and carrying out such an assay, and to methods of making these components. Specifically, tracers, immunogens and antibodies are disclosed, as well as methods for making them. The tracers and the immunogens are made from substituted anilide compounds. A fluorescein moiety is included in the tracer, while a poly-(amino acid) forms a part of the immunogen. The antibodies are prepared in response to the immunogen. The assay is conducted by measuring the degree of polarization retention of plane polarized light that has been passed through a sample containing antiserum and tracer.
[EN] CYANO THIENOTRIAZOLODIAZEPINES AND USES THEREOF<br/>[FR] CYANO-THIÉNOTRIAZOLOAZÉPINES ET LEURS UTILISATIONS
申请人:DANA FARBER CANCER INST INC
公开号:WO2017044849A1
公开(公告)日:2017-03-16
The present invention provides compounds and pharmaceutically compositions thereof. The compounds and compositions are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.
2-Sulfonyliminodihydropyrimidines: A Novel Class of Analgesic Compounds
antinociceptive and anti‐inflammatory activities. The results were compared with that of acetyl salicylic acid. Compounds 6Ab–d and 6Be displayed an interesting analgesic profile in the acetic acid‐induced abdominal contractions test. Based on the results of the carrageenan‐hind paw edema test, compound 6Af showed potential anti‐inflammatory activity.